Richard Cooper is a litigator. Identified as one of "Washington's Top Lawyers" for Food and Drug law by Washingtonian magazine (December 2013), his principal area of practice is food and drug law, particularly relating to medical products, and including advising, and enforcement (e.g., inspections, warning letters, administrative sanctions, injunction proceedings, and criminal proceedings). He was lead counsel in a commercial arbitration that, in 2007, resulted in an award of more than $395 million for his client. Other recent and current matters include litigation over a product-related decision by FDA, defense against a claim of false advertising, defense against claims of improper pharmaceutical pricing, and resolution of FDA enforcement actions. As lead counsel, he argued successfully in FDA v. Brown & Williamson Tobacco Corp., 529 US 120 (2000). He has represented clients in congressional and other hearings. His clients have included major pharmaceutical and other consumer products companies.
Mr. Cooper has taught food and drug law at Georgetown University Law Center (1987-92, 1996), has written extensively in the field, and has served on committees, including: Advisory Panel on Strategies for Medical Technology Assessment, Congressional Office of Technology Assessment (1980-81); Committee on Priority Mechanisms, National Research Council, National Academy of Sciences (1980-83); Editorial Advisory Board, Food & Drug Law Journal (1981-88, 1992-96), Chairman (1995); Committee on Contraceptive Development, National Research Council, National Academy of Sciences (1987-90); Editorial Advisory Board, FDA Enforcement Manual (1993-present); Editorial Advisory Board, Food Safety Law (1994); Board of Directors, Food & Drug Law Institute (2000-02); Chairman of the Board, Business Crimes Bulletin (1995-2006).
Mr. Cooper has frequently served as an expert witness on food and drug matters. He also has served as an arbitrator.
His memberships have included: Georgetown University Law Center Supreme Court Institute (2000-present); Haverford College Board of Managers (1997-2009), Co-Chairman, Finance Committee (2000-2009); Board of Directors, Good Shepherd Ministries, Inc., Washington, DC, and member, Executive Committee (2001-2008); Advisory Board, Jelleff Boys and Girls Club, Washington, DC (1993-2003); Board of Directors, WSC Avant Bard (a theater company) (2004-present); Williams & Connolly Executive Committee (1983-84, 1990-91).
Recognized as a Senior Statesmen in Healthcare: pharmaceutical and medical products regulatory litigation in the 2017 edition of Chambers USA
Named Washington, D.C. "Lawyer of the Year" for FDA Law by The Best Lawyers in America ® 2017
Recognized as one of The Best Lawyers in America ®, 2007-2021
Recognized as a “Life Science Star” in regulatory work by LMG Life Sciences
Other Government Service
Chief Counsel, United States Food and Drug Administration, 1977-1979
Special Assistant to James R. Schlesinger and Senior Member, Office of Energy Policy and Planning, Executive Office of the President, 1977